Ameridge Corporation (KOSDAQ:900100)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	53,670	41,852	65,903	51,335	112,000	74,163
Market Cap Growth	-22.51%	-36.49%	28.38%	-54.16%	51.02%	-29.29%
Enterprise Value	55,354	44,389	61,500	48,038	122,980	132,045
Last Close Price	1166.00	992.00	1694.00	1525.00	3585.00	3585.00
PE Ratio	-	-	-	37.13	22.55	-
PS Ratio	3.39	2.20	1.72	0.78	1.37	1.00
PB Ratio	1.35	1.05	1.48	0.75	2.04	2.33
P/TBV Ratio	2.38	1.84	1.98	0.90	2.52	5.92
P/FCF Ratio	-	-	-	-	-	12.67
P/OCF Ratio	-	-	-	12.30	-	11.72
EV/Sales Ratio	3.50	2.34	1.60	0.73	1.51	1.78
EV/EBITDA Ratio	-	-	-	6.97	20.30	49.30
EV/EBIT Ratio	-	-	-	22.28	47.80	-
EV/FCF Ratio	-	-	-	-	-	22.55
Debt / Equity Ratio	0.07	0.15	0.03	0.12	0.28	1.09
Debt / EBITDA Ratio	-	-	-	1.15	2.51	12.89
Debt / FCF Ratio	-	-	-	-	-	5.90
Asset Turnover	0.31	0.40	0.62	0.89	1.09	0.67
Inventory Turnover	6.63	5.73	4.24	5.21	8.99	8.01
Quick Ratio	0.71	1.53	2.69	1.25	1.25	0.44
Current Ratio	1.39	2.45	6.28	2.69	3.04	0.93
Return on Equity (ROE)	-37.88%	-37.86%	-62.89%	2.25%	11.47%	-34.83%
Return on Assets (ROA)	-16.89%	-17.62%	-18.53%	1.81%	2.14%	-0.74%
Return on Capital (ROIC)	-18.88%	-18.46%	-18.91%	1.84%	2.36%	-0.92%
Return on Capital Employed (ROCE)	-	-	-	3.10%	4.00%	-
Earnings Yield	-29.47%	-38.22%	-53.91%	2.69%	4.43%	-12.10%
FCF Yield	-	-21.68%	-4.99%	-0.54%	-17.44%	7.90%
Buyback Yield / Dilution	-11.94%	-12.73%	-15.06%	-12.92%	-34.99%	-12.83%

Updated Nov 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.